Nobuhiro Tahara
-
- Cardiovascular Disease and Adiposity 8
- Cardiovascular Function and Risk Factors 8
-
- Pulmonary Hypertension Research and Treatments 18
- Cerebrovascular and Carotid Artery Diseases 13
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis 7
- Clinical Biochemistry top 2%
- Advanced Glycation End Products research 9
-
- Sarcoidosis and Beryllium Toxicity Research 7
-
- Amyloidosis: Diagnosis, Treatment, Outcomes 7
- Co-authors
- Tsutomu ImaizumiHisashi KaiHayato KaidaMasatoshi IshibashiNaofumi HayabuchiKenkichi BabaHiroyuki NakauraSho‐ichi Yamagishi
- Cited by
- Cardiology and Cardiovascular MedicinePulmonary and Respiratory MedicineClinical Biochemistry
- Journals
- Nature Medicine (1 paper)Journal of the American College of Cardiology (4 papers)PLoS ONE (1 paper)
- Partner nations
- JapanUnited StatesNetherlands
In The Last Decade
Nobuhiro Tahara
87 papers receiving 2.7k citations
Peers
Comparison fields: 5 of 105
- Cardiology and Cardiovascular Medicine 1.0k
- Pulmonary and Respiratory Medicine 1.1k
- Clinical Biochemistry 227
- Radiology, Nuclear Medicine and Imaging 724
- Endocrinology, Diabetes and Metabolism 331
Countries citing papers authored by Nobuhiro Tahara
This map shows the geographic impact of Nobuhiro Tahara's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nobuhiro Tahara with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nobuhiro Tahara more than expected).
Fields of papers citing papers by Nobuhiro Tahara
This network shows the impact of papers produced by Nobuhiro Tahara. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nobuhiro Tahara. The network helps show where Nobuhiro Tahara may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Nobuhiro Tahara, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2023 | 7 | |
| 3 | 2023 | 2 | |
| 4 | 2023 | 2 | |
| 5 | 2021 | 13 | |
| 6 | 2021 | 30 | |
| 7 | 2020 | 2 | |
| 8 | 2019 | 5 | |
| 9 | 2017 | 4 | |
| 10 | 2016 | 2 | |
| 11 | 2016 | 6 | |
| 12 | 2015 | 43 | |
| 13 | 2015 | 3 | |
| 14 | 2013 | 47 | |
| 15 | 2012 | 28 | |
| 16 | 2011 | 41 | |
| 17 | 2010 | 166 | |
| 18 | 2009 | 49 | |
| 19 | 2006 | 478 | |
| 20 | 2004 | 7 |
About Nobuhiro Tahara
Nobuhiro Tahara is a scholar working on Cardiology and Cardiovascular Medicine, Pulmonary and Respiratory Medicine and Clinical Biochemistry, having authored 98 papers that have together received 2.8k indexed citations. Recurring topics across this work include Pulmonary Hypertension Research and Treatments (18 papers), Cerebrovascular and Carotid Artery Diseases (13 papers), Advanced Glycation End Products research (9 papers), Cardiovascular Disease and Adiposity (8 papers), Cardiovascular Function and Risk Factors (8 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (7 papers), Sarcoidosis and Beryllium Toxicity Research (7 papers) and Amyloidosis: Diagnosis, Treatment, Outcomes (7 papers). The work is most often cited by research in Cardiology and Cardiovascular Medicine (1.0k citations), Pulmonary and Respiratory Medicine (1.1k citations) and Clinical Biochemistry (227 citations). Nobuhiro Tahara has collaborated with scholars based in Japan, United States and Netherlands. Frequent co-authors include Tsutomu Imaizumi, Hisashi Kai, Hayato Kaida, Masatoshi Ishibashi, Naofumi Hayabuchi, Kenkichi Baba, Hiroyuki Nakaura, Sho‐ichi Yamagishi, Atsuko Tahara and Minori Mizoguchi. Their work appears in journals such as Nature Medicine, Journal of the American College of Cardiology and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.